Physician profile
Andrew C Elson
NPI 1649596107
$2,323.87
in general payments reported to CMS, 2019-2025
18 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 88% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2022: $91.01 · 2023: $137 · 2024: $441 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.00 |
| Travel and Lodging | $908.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,413.90 | 2025 | Varian Ethos Treatment Planning, Varian Treatment, Truebeam |
| Novocure INC. | $154.78 | 2024 | Optune |
| Sumitomo Pharma America, INC. | $135.90 | 2023-2025 | Orgovyx |
| Teleflex LLC | $98.57 | 2024 | |
| Profound Medical Corp. | $91.01 | 2022 | |
| Boston Scientific Corporation | $81.55 | 2019 | |
| Daiichi Sankyo INC. | $71.82 | 2023-2025 | Enhertu |
| Janssen Biotech, INC. | $63.85 | 2024-2025 | Darzalex, Talvey |
| Novartis Pharmaceuticals Corporation | $34.34 | 2023 | |
| Adaptive Biotechnologies Corporation | $25.22 | 2025 | Clonoseq |
| Bioprotect Medical, INC. | $22.98 | 2025 | Bioprotect Balloon Implant System |
| Sobi, INC | $21.67 | 2024 | |
| Exelixis INC. | $20.06 | 2023 | Cabometyx |
| Tactile Systems Technology INC | $19.67 | 2025 | Nimbl, Flexitouch Plus |
| Ge Healthcare | $18.52 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $17.59 | 2025 | |
| Apellis Pharmaceuticals, INC. | $16.92 | 2023 | Empaveli |
| Incyte Corporation | $15.52 | 2024 | Monjuvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Elson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.